HIGHLIGHTS
- who: Liuyun Zhang from the San Raffaele Hospital (IRCCS), Italy University of Michigan, United States have published the Article: Gut microbiome in multiple myeloma: Mechanisms of progression and clinical applications, in the Journal: Gut microbiota and immune responses
- future: Microbiome data are generally not readily available in real-time in the clinic and therefore are usually retrospective and cannot currently be used to predict future clinical events. More studies are needed to explore whether biomarkers from the microbiome will have clinical relevance in MM. differences in the degree of damage to gut microbes by different . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.